New investments underscore the accelerating institutional adoption of the Canton Network

NEW YORK, Dec. 4, 2025 — Digital Asset, the creator of the Canton Network and a leader in privacy-enabled blockchain technology for global financial markets, today announced a new strategic investment from BNY, iCapital, Nasdaq, and S&P Global. Their participation reflects the accelerating convergence of traditional finance (TradFi) and decentralized finance (DeFi) towards an “AllFi” future on the Canton Network.

These investments build on Digital Asset’s strong momentum following recent funding milestones and underscore the growing institutional alignment behind the Canton Network– the only public, permissionless Layer-1 blockchain designed with configurable privacy, institutional-grade compliance, and the ability to support hundreds of billions of dollars in onchain real-world assets.

The new strategic partners represent leading global institutions in asset servicing, wealth management, market infrastructure, financial data, financial technology, and digital asset trading. Their investment reinforces the critical role Canton is playing in the next phase of financial market infrastructure, bringing together decentralization with the privacy, legal certainty, and regulatory compliance required by global markets.

Today, the Canton Network underpins a diverse and rapidly expanding set of use cases, including bonds, equities, money market funds, alternative investment funds, commodities, repos, mortgages, life insurance, and annuities. With more than $6 trillion of assets onchain, over 600 institutions now participate across the Canton ecosystem, including global leaders in both traditional and decentralized finance.

Yuval Rooz, CEO of Digital Asset:
“Institutions across the financial ecosystem recognize the necessity of blockchain infrastructure purpose-built for regulated markets. The addition of BNY, iCapital, S&P Global, and Nasdaq marks another milestone in the evolution of both Digital Asset and Canton. Their participation reinforces the inevitability of interoperable, privacy-enabled markets operating at global scale. We look forward to deepening our collaboration as we continue to transform how onchain real-world assets move, settle, and interconnect.”

Brian Ruane, Head of Global Clearing, Credit Services & Corporate Trust, BNY:
“As capital markets move faster towards a real-time, always-on operating model, the development of financial infrastructure that seamlessly connects digital and traditional markets has never been more important. We’re excited to work with Digital Asset and Canton to continue advancing privacy-enabled and interoperable settlement solutions at institutional scale. This investment reflects our commitment to reimagining a faster and more efficient future for financial market infrastructure.”

Lawrence Calcano, Chairman and CEO, iCapital:
“By investing in Digital Assets, the leader in blockchain innovation, iCapital is reinforcing its commitment to building next-generation financial infrastructure. By combining our expertise in private markets and proven technology with Canton’s blockchain platform, we are establishing the foundation for tokenization of alternatives—driving efficiency, transparency, and broader access across the investment ecosystem.”

Tal Cohen, President ofNasdaq:
“We’re excited to deepen our relationship with Digital Asset and the Canton Network as we continue building the next generation of institutional market infrastructure. This investment builds on the work we’ve already done together to modernize post-trade and collateral workflows, and positions us to accelerate adoption of interoperable, tokenized solutions across the global capital markets. By combining Nasdaq’s markets and infrastructure expertise with Digital Asset’s technology, we can help our clients unlock new efficiencies, better manage risk, and confidently participate in the evolving digital asset ecosystem.”

Swati Sawjiany, Global Head of Enterprise Strategy, M&A and Investments, S&P Global:
“The accelerated convergence of off-chain and on-chain financial markets underscores the importance of trusted market data, industry-leading benchmarks, and risk assessments as critical enablers in the transformation of market infrastructure. Digital Asset Holdings has played a central role in building a public blockchain capable of supporting the privacy and compliance demands of financial institutions. We are excited to join this round and see opportunity to collaborate with Canton and network participants to enhance transparency, integrity, and insight to digital markets.”

About Digital Asset:
Digital Asset is a leading innovator in blockchain technology, transforming traditional and digital financial markets with privacy-enabled solutions that improve capital flow and create a more efficient, fair, and resilient global system. As the creator of the Canton Network, the only public layer one blockchain with privacy, and a founding member of its Canton Foundation, Digital Asset has been a pioneer of this open, secure, and interoperable infrastructure. Founded in 2014, Digital Asset is committed to reshaping the future of finance by enabling real-time efficiencies, 24/7 global transactions, and unlocking the full potential of cryptocurrencies, digital assets, and the continued convergence of decentralized and traditional finance.

About the Canton Network:
The Canton Network is the only public, permissionless blockchain purpose-built for institutional finance–uniquely combining privacy, compliance, and scalability. Governed by the Canton Foundation with participation from leading global financial institutions, Canton enables real-time, secure synchronization and settlement across multiple asset classes on a shared, interoperable infrastructure. The open-sourced network is powered by its native token, Canton Coin, and supports decentralized governance and collaborative application development. It’s the proven link between the promise of blockchain and the power of global finance, making finance flow the way it should. Learn more at: canton.network.

Contact:
Paul Patella
914-645-8662
[email protected]

SOURCE Digital Asset (US) Corp.

COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 — Paradigm Health, the technology company rebuilding the clinical research ecosystem, today announced an oversubscribed $78 million Series B financing. The round was led by ARCH Venture Partners, with participation from new investor DFJ Growth and existing investors F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital, the American Cancer Society’s BrightEdge Fund, and others, several of whom took super pro-rata positions.

Paradigm Health is transforming how clinical trials are conducted and broadening access for patients across the U.S. and globally. The new funding will be used to accelerate Paradigm Health’s expansion as demand grows from global biopharmaceutical companies for more efficient trials and from health systems seeking to offer trials to patients closer to where they receive routine care. Paradigm Health currently supports Phase I–III oncology trials for 15 of the top 20 global pharmaceutical companies.

“When trials run more efficiently, new treatments reach patients sooner,” said Robert Nelsen, Managing Partner at ARCH Venture Partners and Paradigm Health Co-Founder and Board Chair. “Paradigm Health is creating new infrastructure the industry desperately needs: one platform that enables hospitals and sponsors to run studies faster, more intelligently, and at far lower cost. This will accelerate the development of promising therapies and help ensure today’s patients have access to the treatments they need.”

Following Paradigm Health’s acquisition of Flatiron Health’s Clinical Research Business, the company now operates the largest oncology research network in the United States and is expanding its commercial business across neuroscience, cardiovascular disease, metabolic conditions, and other therapeutic areas with significant research needs.

“Clinical trials are how we learn and improve care for patients,” said Kent Thoelke, Chief Executive Officer of Paradigm Health. “Today, most research happens in academic centers because they have the staff and infrastructure to manage it. Patients in community and rural settings have limited access to trials, and their experiences remain underrepresented in research. This slows down trials, makes them more expensive, and misses opportunities for innovation. Paradigm Health is building a scalable trial ecosystem embedded directly into real-world clinical workflows, enabling any health system to participate in research with dramatically fewer resources.”

Paradigm Health’s platform now spans 45 U.S. states and 166 healthcare provider organizations with 2,100 care locations, placing 70% of the U.S. cancer population within easy access to a clinical trial site. This includes 123 community oncology practices and 43 health systems and academic medical centers, 23 of which are NCI-Designated Cancer Centers. The company’s AI-enabled infrastructure automates patient matching and site feasibility, and has helped health systems accrue to trials four times faster while reducing provider burden and accelerating timelines for biopharma sponsors. Paradigm Health also recently launched a Trial Design Service to enable sponsors to design and execute interventional and pragmatic trials embedded directly into routine care.

“Clinical trials are the bottleneck in getting new therapies to patients, especially as AI unlocks an unprecedented wave of drug innovation,” said Justin Kao, Partner at DFJ Growth. “Paradigm Health is the AI-native platform built for this moment, pairing breakthrough technology with the largest clinical network to make trials dramatically faster and more accessible. We’re excited to support the team as they democratize access to cutting edge therapies.”

With its national network, AI-powered platform, and trial-design capabilities, Paradigm Health is the leading partner for biopharma companies and health systems working to make clinical research a seamless part of patient care in every community where it’s needed.

About Paradigm Health‍
Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster. For more information, visit https://www.paradigmhealth.ai   

SOURCE Paradigm Health, Inc.

Eine einzigartige Investition des Quantenhandelsriesen signalisiert einen Wandel in der Art und Weise, wie komplexe Systeme getestet werden.

TYSONS CORNER, Virginia, 4. Dezember 2025 — Antithesis gab heute eine Serie-A-Runde in Höhe von 105 Millionen US-Dollar unter der Leitung von Jane Street bekannt, dem globalen technologiegetriebenen quantitativen Handelsunternehmen, das für den Aufbau einiger der weltweit fortschrittlichsten Softwaresysteme bekannt ist. Die Investition unterstreicht die Bedeutung von Antithesis als kritische Infrastruktur für Unternehmen, die komplexe, verteilte Systeme betreiben. Jane Street ist sowohl Investor als auch Kunde von Antithesis.

Zu den weiteren Investoren gehören Amplify Venture Partners, Spark Capital, Tamarack Global, First In Ventures, Teamworthy Ventures, Hyperion Capital sowie Privatpersonen wie Patrick Collison, Dwarkesh Patel und Sholto Douglas sowie weitere neue und wiederkehrende Investoren. Das Kapital wird verwendet, um die Produktinnovation von Antithesis zu beschleunigen und die Marktpräsenz in Nordamerika, Europa sowie Asien zu erhöhen.

Softwaresysteme sind komplexer geworden, und da KI das Volumen des produzierten Codes beschleunigt, können herkömmliche Tests nicht mehr Schritt halten. Heutzutage verlassen sich die meisten Unternehmen immer noch auf beispielbasierte Tests (ob von Ingenieuren oder von KI geschrieben). Diese Methoden erfassen zwar oberflächliche Probleme, können jedoch nicht zuverlässig die tiefgreifenden, sich entwickelnden Verhaltensweisen aufdecken, die zu Ausfällen, Datenbeschädigungen und kaskadenartigen Systemausfällen führen.

Antithesis ersetzt dies durch deterministische Simulationstests: Es wird eine vollautomatisierte, massiv parallele Simulation des zu validierenden Systems ausgeführt, die monatelanges Verhalten in der produktiven Umgebung auf wenige Stunden verdichtet. Die Plattform untersucht Randfälle, injiziert häufige Fehler, validiert die Korrektheit und reproduziert jeden Fehler perfekt, sodass Ingenieure Probleme mit beispielloser Geschwindigkeit sowie Zuverlässigkeit beheben können.

„Software ist heute die Grundlage von allem, und je komplexer und verteilter Systeme werden, desto mehr braucht die Welt ein neues Testmodell, das Korrektheit garantiert”, sagte Will Wilson, Geschäftsführer von Antithesis. „Mit dieser Finanzierung bauen wir die Infrastruktur aus, die Zuverlässigkeit nicht nur erreichbar, sondern zur Selbstverständlichkeit macht, so wie wir auch erwarten, dass Ampeln jedes Mal funktionieren. Unsere Kundschaft beweist bereits, dass deterministisch validierte Systeme schneller ausgeliefert werden, ohne zu versagen, und ein tieferes Vertrauen schaffen.”

„Jane Street betreibt einige der anspruchsvollsten verteilten Systeme der Welt, und Antithesis hat uns geholfen, Probleme aufzudecken, die keine andere Testmethode finden konnte”, sagte Doug Patti, Ingenieur bei Jane Street. „Wir legen die Messlatte für Technologien, auf die wir uns verlassen, sehr hoch und für Unternehmen, in die wir investieren, sogar noch höher. Es ist zwar selten, dass wir eine frühe Runde leiten, aber Antithesis ist uns um Jahre voraus, und wir glauben, dass deterministische Simulationstests in allen Branchen grundlegend sein werden.”

Auswirkungen auf Kunden in den Bereichen Finanzen, KI, Blockchain und Dateninfrastruktur
Antithesis wird bereits von Unternehmen eingesetzt, deren Systeme nicht ausfallen dürfen:

• Jane Street verlässt sich auf Antithesis, um komplexe verteilte Systeme zu validieren, die für den Betrieb ihres globalen Handelsgeschäfts entscheidend sind.
• Ethereum nutzte Antithesis, um sein globales Netzwerk unter extremen Bedingungen vor The Merge zu simulieren und kritische Probleme aufzudecken, die den historischen Übergang auf Proof of Stake hätten gefährden können.
• MongoDB nutzt Antithesis, um Kernkomponenten seiner Datenbankplattform rigoros zu testen und hilft den Ingenieuren, subtile Probleme zu erkennen, bevor sie die Kunden erreichen.

Diese Beispiele spiegeln einen schnell wachsenden Kundenstamm in den Bereichen Finanzwesen, Infrastrukturplattformen und Organisationen wider, die fortschrittliche KI-Systeme entwickeln. Antithesis hat seinen Umsatz in den vergangenen zwei Jahren um mehr als das Zwölffache gesteigert und wächst weiterhin rasant.

Verwendung der Mittel
Mit der neuen Finanzierung wird Antithesis:

• Engineering-Teams erweitern, um ihre deterministische Simulations-Engine weiter zu stärken
• Die Analysefähigkeit und Autonomie der Plattform weiter ausbauen
• Eine erstklassige Vertriebs- und Marketingorganisation aufbauen
• Markteinführungsaktivitäten in Nordamerika, Europa und Asien skalieren
• Die Verfügbarkeit über Cloudkanäle, einschließlich des AWS Marketplace, weiter ausbauen

Informationen zu Antithesis
Antithesis ist ein grundlegend neuer Weg, um zu überprüfen, ob Software korrekt funktioniert, bevor sie veröffentlicht wird. Es führt eine vollständig deterministische, massiv-parallele Simulation durch, die in wenigen Stunden eine jahrelange Produktion unter realen Bedingungen testet. Antithesis erforscht auf intelligente Weise die entlegensten Winkel Ihrer Codebasis und fügt strategisch häufige Fehler ein, um sicherzustellen, dass sich das System immer wie vorgesehen verhält. Die Plattform reproduziert jeden gefundenen Fehler exakt in ihrer einzigartigen Umgebung zur schnellen Fehlerbehebung. Das Unternehmen hat seinen Sitz in Nord-Virginia, wurde 2018 gegründet und ist 2024 aus dem Stealth-Modus hervorgegangen. Weitere Informationen finden Sie auf https://antithesis.com/.

Informationen zu Jane Street
Jane Street ist ein globales, technologieorientiertes Handels- und Investmentunternehmen. Das im Jahr 2000 gegründete Unternehmen bietet einen forschungsorientierten Ansatz sowie quantitatives Fachwissen für Märkte auf der ganzen Welt und ist mit mehr als 3000 Beschäftigten in Büros in New York, London, Hongkong, Singapur sowie Amsterdam vertreten. Weitere Informationen finden Sie auf www.janestreet.com.

Logo – https://mma.prnewswire.com/media/2836754/Antithesis_Logo.jpg

NOVATO, Calif., Dec. 3, 2025 — Circulate Health, a leader in precision Therapeutic Plasma Exchange (TPE) technologies and microplastics technologies, announces today a strategic investment from Scrum Ventures, a global early-stage venture capital firm known for its strong focus on sports, human performance, and next-generation health technologies. The seven-figure investment will accelerate Circulate’s ongoing growth.

“We’re entering a new era where more and more consumers are recognizing the benefits of TPE,” said Brad Younggren, Circulate’s CEO & Co-Founder. “Partnering with Scrum Ventures allows us to expand our research and continue the momentum we’ve seen since inception.”

Circulate Health’s platform leverages advanced TPE technology designed to remove circulating microplastics, environmental toxins, inflammatory markers, and other microscopic pollutants. Early research suggests that these particles may accumulate over time, contributing to systemic inflammation, oxidative stress, and potential long-term health challenges.

“The shift toward proactive, science-backed longevity care is one of the most important movements in modern health,” said Michael Proman, Partner at Scrum Ventures. “Circulate is positioned at the center of that transformation—they’re building the first truly scalable, patient-centered platform in therapeutic plasma exchange.”

This partnership signals the convergence of two rapidly growing fields and will help further advance their respective industries in the coming months.

About Circulate Health
Backed by Khosla Ventures, Circulate Health is pioneering technologies to reverse aging and improve health outcomes. Learn more at https://www.circulate.health/.

About Scrum Ventures
Scrum Ventures is a seed-stage venture capital firm based in San Francisco and Tokyo, investing in innovative companies across industries such as health, sports, mobility, and AI & robotics. Through its global network and Scrum Studio open innovation platform, the firm supports startups advancing athlete performance, wellness, and next-generation sports technology, and more. Learn more at Scrum.vc.

SOURCE Circulate Health

• Pantera Capital leads $17M Series A raise, joined by Sequoia and Samsung Next. 
• Fin is building a next-generation global payments platform combining stablecoin speed with financial reliability.
• Founded by Citadel alumni, Fin has attracted top talent from Google, Meta, Uber, Rippling and Chime. 

NEW YORK, Dec. 3, 2025 — Fin, a next-generation payments company enabling instant, high-value, global transactions, today announced it has raised a $17 million Series A led by Pantera Capital, with participation from top-tier investors including Sequoia Capital and Samsung Next. The Series A will fund team expansion and bring Fin’s stablecoin‑powered payments product to market, launching soon with early users including global enterprises, financial institutions, and crypto-native businesses seeking faster, more reliable payment rails.

Today, moving millions across borders means delays, opaque fees, and operational complexity. By pairing stablecoin speed with bank‑grade reliability, Fin offers a simple, trusted, borderless way to move money. Users and businesses can send instant, large‑value payments to other Fin users, directly into bank accounts, or across crypto rails.

“It’s difficult for incumbents to rip out their whole infrastructure and build a proper payments product in the new global stablecoin regime,” said Ian Krotinsky, co-founder of Fin. “That difficulty is our opportunity.”

“This team has repeatedly shown they can build crypto products that don’t feel like crypto—simple, intuitive, and ready for real-world users,” said Ryan Barney, Partner at Pantera Capital. “Fin brings that same product DNA to high-value global payments, stepping into a massive global opportunity.”

About Fin

Fin is a next-generation payments company built for high-value, global, and instant transactions. Powered by stablecoins and engineered for reliability, Fin enables businesses and individuals to move millions of dollars instantly—whether to bank accounts, across borders, or between Fin users. Founded by Ian Krotinsky and Aashiq Dheeraj, both ex-Citadel, and built by the team that created TipLink, Fin is reimagining how money moves worldwide.

For more information about Fin, please visit fin.tech and follow x.com/fin. Inquiries can be directed to [email protected].

Contact
Sarah Cohen
SJC PR
[email protected] 

Photo – https://mma.prnewswire.com/media/2836977/Fin.jpg

SOURCE Fin

NEW YORK, Dec. 3, 2025 — Supper, the agentic data platform that removes the agony of accessing company data, today announced an $11 million seed round led by Union Square Ventures (USV) with participation from BoxGroup, Inspired Capital, Torch Capital, and Avid Ventures. The funding accelerates Supper’s push to help leaders at high-growth companies get fast, reliable answers to their most important business questions.

Supper is co-founded by Lowell Putnam, who previously founded Quovo (acquired by Plaid), and Andrew Salamon, a co-founder of Hims & Hers; bringing together a track record of building companies with billions of dollars in public and private market exits.

“At fast-growing companies, teams burn hours every week wrangling data — rewriting SQL, chasing definitions, stitching numbers together in Excel they don’t even trust. It’s a hidden tax that shows up in board decks, team meetings, even one-on-ones,” shares Lowell Putnam, Co-founder and CEO of Supper. “Supper cuts that out. You just ask a question, get an insight, and move on. Decisions get faster, trust gets stronger, and everyone stays aligned.”

“We built Supper to feel simple on the surface. Behind the scenes, it’s incredibly powerful. The platform aggregates and cleanses customers’ data, builds out their semantic layer, and maintains data security so anyone can get answers they trust, fast,” said Andrew Salamon, Co-founder and President of Supper.

“We see enormous potential in tools that turn data into collective knowledge and sources of trust,” said Rebecca Kaden, Managing Partner at Union Square Ventures. “Supper delivers on that vision, and Lowell and Andy’s experience as founders makes them the right team to solve the problem.”

Business users gain reliable, self-serve access to data, freeing engineering and analytics teams from ad-hoc requests and dashboard work. That time shifts back to product velocity and growth.

“With Supper, our engineering team saves 7–8 hours every week on query requests from our CEO, COO, and GTM teams. It’s modernized how we work with data and helps everyone move faster,” said the CTO at a Series A SaaS company.

About Supper
Supper is the agentic data platform that knows your business as well as you do. Supper allows fast-growing companies to directly integrate with both SaaS tools and data warehouses, then it cleanses and normalizes data to make it human readable and completely semantic. Supper’s agent suite answers critical business questions, builds complex dashboards, and supercharges research projects – allowing data-driven businesses to make faster, smarter decisions. Learn more at supper.co.

Media Contact: [email protected]

About USV
Union Square Ventures is a small, collegial partnership based in New York City. We are generalist investors, working across many sectors and technologies, but with a consistent point of view on how to approach transformative opportunities. Learn more at usv.com

SOURCE Supper

TORONTO, Dec. 3, 2025 — Urban Poling Inc.- We are proud to announce that we are now the newest Bronze Partner in Research of The Foundation for Physical Therapy Research. This partnership reflects our strong commitment to supporting evidence-based physical therapy and advancing research to optimize health outcomes for communities nationwide.

“We are honored to be partnered with the Foundation for Physical Therapy Research,” said Diana Oliver, Owner and CEO of Urban Poling Inc. “Evidence and supporting research have been paramount to the integrity of our products and educational programs since our company’s inception. Our commitment to research guides our approach to the industry, our partners, professionals, and end users. We believe deeply in the importance of the Foundation’s work.”

About the Foundation for Physical Therapy Research
The Foundation for Physical Therapy Research is an independent, 501(c)(3) charitable organization dedicated to funding physical therapy research and developing researchers to optimize movement and health. For more than 45 years, the Foundation has awarded over $24 million in research grants, scholarships, and fellowships. As the research funding organization of APTA, it remains the only national nonprofit solely focused on supporting physical therapy research. Supporters of the Foundation for Physical Therapy Research who wish to learn more about Urban Poling Inc.’s accredited education programs for the physical therapy community are invited to connect with their team at [email protected] and mention the Foundation. This educational opportunity is offered independently by Urban Poling Inc.

Urban Poling Inc. is dedicated to making rehabilitation accessible, engaging, and tailored to individual needs. Their support of the Foundation’s mission highlights a shared belief that research drives innovation, advances the physical therapy profession, and improves patient care through active living.

 “We are grateful to Urban Poling Inc. for becoming a Partner in Research and supporting our mission,” says Paul Rockar, PT, DPT, MS, FAPTA, President of the Foundation.  “We’re fortunate to receive support from companies like Urban Poling Inc. that understand the importance of investing in physical therapy research and advancing the evidence base for our profession.”

About Urban Poling Inc: Urban Poling Inc. is a global leader in the promotion of rehabilitation, fitness and wellness through specialized poles and programs which promote pole walking and pre-gait exercises. Known for its’ innovative Activator® Poles which were designed by an OT and gerontologist, Urban Poling Inc focuses on improving mobility, stability, and overall quality of life for all ages and stages but most especially individuals with balance disorders, neurological conditions, arthritis and those in post-surgical rehabilitation. The company’s products and programs are recommended by leading healthcare professionals worldwide, and Urban Poling Inc is dedicated to empowering people of all ages to live active, healthy lifestyles through doing what the body was designed to do – MOVE.

We are proud to collaborate with The Foundation of Physical Therapy Research to advance evidence-based physical therapy and patient care. Together, we are taking healthy strides forward to promote active living and improved mobility!

Our poles are available through Urban Poling.com,  Amazon.com and select CVS stores.  For additional locations please visit our Find A Retailer or distributor to locate a store nearest you.

For media inquiries, please contact:
Diana Oliver
416.668.0116
[email protected] 

SOURCE Urban Poling Inc.

HOUSTON, Dec. 3, 2025 — Sembix, the AI-powered modernization company transforming how public sector organizations modernize legacy systems today announced that its software and services are now available through CarahSoft Technology Corp. under the Texas Department of Information Resources (DIR) and NASPO ValuePoint cooperative purchasing programs. This milestone expands access to Sembix’s AI modernization solutions nationwide – enabling government, education, and nonprofit organizations a faster, compliant, and more cost-effective way to procure Sembix’s technology and expertise.

Transforming the Public Sector Through AI-Driven Modernization

At Sembix, our mission is to help organizations break free from legacy constraints and accelerate innovation through intelligent, AI-driven modernization. Our platform blends the power of Generative AI with human expertise to deliver rapid, repeatable outcomes at enterprise scale.

With availability through CarahSoft’s public sector contract portfolios, agencies can now procure Sembix solutions using pre-negotiated cooperative contracts—eliminating lengthy procurement cycles and enabling faster digital transformation.

“Public agencies shouldn’t have to wait years to modernize,” said Danny Weldon, Co-Founder and CEO of Sembix. “Through Texas DIR and NASPO ValuePoint, agencies now have a simpler, compliant path to access cutting-edge AI technology that’s guided by human expertise and focused on measurable results.”

Streamlining Procurement Through Trusted Contract Vehicles

Texas Department of Information Resources (DIR): Enables Texas state and local government agencies – and eligible entities nationwide through interlocal cooperation agreements—to access technology solutions under competitively sourced contracts.

NASPO ValuePoint: Offers a nationwide cooperative purchasing program that allows participating states and public sector organizations to buy IT solutions under standardized, pre-competed terms.

Together, these programs provide a faster, more efficient path for agencies to access Sembix’s modernization solutions without issuing new RFP’s.

Modernization Powered by AI and Guided by Experts

Sembix delivers fixed-price, outcome-based solutions designed specifically for the public sector. Our offerings help agencies:

• Modernize legacy applications and migrate to cloud-native architectures
• Automate complex workflows and data processes
• Integrate AI to enhance efficiency, insight, and service delivery
• Improve citizen experiences while reducing technical debt

Sembix solutions are built for compliance, transparency, and measurable public impact – Powered by AI, Guided by Experts™.

About Sembix

Sembix helps organizations modernize legacy systems and accelerate transformation through AI-driven workflows and expert guidance. Founded in 2024, Sembix is pioneering a future of autonomous, multithreaded modernization – where legacy systems evolve into modern, cloud-native applications with minimal manual effort.

Visit www.sembix.ai to learn more.

About CarahSoft

CarahSoft Technology Corp. is The Trusted Government IT Solutions Provider®, supporting public sector organizations across federal, state, and local government and education. Working with resellers, systems integrators, and consultants, CarahSoft provides solutions for cybersecurity, multi-cloud, DevSecOps, AI, and more. Learn more at www.carahsoft.com.

Media Contact

Press Inquiries:
John Flaherty
Sembix, LLC
Phone: 713-588-0505
Email: [email protected]

SOURCE Sembix LLC

-Jane Street lidera la ronda Serie A de 105 millones de dólares de Antithesis para convertir las pruebas de simulación determinista en el nuevo estándar

Una inversión única del gigante del trading cuantitativo marca un cambio en la forma en que se evaluarán los sistemas complejos.

TYSONS CORNER, Va., 3 de diciembre de 2025 — Antithesis anunció hoy una ronda de financiación Serie A de 105 millones de dólares liderada por Jane Street, la firma global de trading cuantitativo basada en tecnología, conocida por desarrollar algunos de los sistemas de software más avanzados del mundo. La inversión subraya el surgimiento de Antithesis como infraestructura crítica para empresas que operan sistemas complejos y distribuidos. Jane Street es inversora y cliente de Antithesis.

Entre los inversores adicionales se incluyen Amplify Venture Partners, Spark Capital, Tamarack Global, First In Ventures, Teamworthy Ventures, Hyperion Capital y personas como Patrick Collison, Dwarkesh Patel y Sholto Douglas, junto con otros inversores nuevos y recurrentes. El capital se utilizará para acelerar la innovación de productos de Antithesis y escalar sus operaciones de comercialización en Norteamérica, Europa y Asia.

Los sistemas de software se han vuelto más complejos y, a medida que la IA acelera el volumen de código producido, las pruebas tradicionales no pueden seguir el ritmo. Hoy en día, la mayoría de las organizaciones aún dependen de pruebas basadas en ejemplos (ya sea desarrolladas por ingenieros o por IA). Estos métodos detectan problemas superficiales, pero no pueden exponer de forma fiable los comportamientos profundos y emergentes que causan interrupciones, corrupción de datos y fallos en cascada del sistema.

Antithesis sustituye esto por pruebas de simulación deterministas: ejecuta una simulación totalmente automatizada y masivamente paralela del sistema que se está validando, que comprime meses de comportamiento de producción en horas. La plataforma explora casos extremos, inyecta fallos comunes, valida la corrección y reproduce perfectamente cualquier fallo para que los ingenieros puedan solucionar problemas con una velocidad y una confianza sin precedentes.

“El software ahora lo sustenta todo, y a medida que los sistemas se vuelven más complejos y distribuidos, el mundo necesita un nuevo modelo de pruebas que garantice la precisión”, afirmó Will Wilson, consejero delegado de Antithesis. “Con esta financiación, ampliamos la infraestructura que hace que la fiabilidad no solo sea alcanzable, sino esperable, tal como esperamos que los semáforos funcionen siempre. Nuestros clientes ya están demostrando que los sistemas validados determinísticamente se entregan más rápido, sin fallos, y generan una mayor confianza”.

“Jane Street gestiona algunos de los sistemas distribuidos más exigentes del mundo, y Antithesis nos ha ayudado a descubrir problemas que ningún otro método de pruebas podría detectar”, afirmó Doug Patti, ingeniero de Jane Street. “Tenemos estándares muy altos para la tecnología en la que confiamos, y estándares aún más altos para las empresas en las que invertimos. Si bien liderar una ronda temprana es poco común para nosotros, Antithesis lleva años de ventaja, y creemos que las pruebas de simulación deterministas se convertirán en fundamentales en todos los sectores”.

Impacto en el cliente en finanzas, IA, blockchain e infraestructura de datos
Antithesis ya es utilizado por organizaciones cuyos sistemas no pueden fallar:

• Jane Street depende de Antithesis para validar sistemas distribuidos complejos, esenciales para el funcionamiento de su negocio de comercio global.
• Ethereum utilizó Antithesis para simular su red global en condiciones extremas antes de la Fusión, lo que reveló problemas críticos que podrían haber puesto en peligro la histórica transición a la Prueba de Participación.
• MongoDB utiliza Antithesis para probar rigurosamente los componentes principales de su plataforma de bases de datos, lo que ayuda a los ingenieros a detectar problemas sutiles antes de que afecten a los clientes.

Estos ejemplos reflejan una base de clientes en rápida expansión en el sector financiero, plataformas de infraestructura y organizaciones que desarrollan sistemas avanzados de IA. Antithesis ha multiplicado sus ingresos por más de 12 en los últimos dos años y continúa creciendo rápidamente.

Uso de los fondos
Con la nueva financiación, Antithesis:

• Ampliará los equipos de ingeniería para fortalecer su motor de simulación determinista
• Mejorará la inteligencia y la autonomía de la plataforma
• Desarrollará una organización de ventas y marketing de primer nivel
• Escalará las operaciones de GTM en Norteamérica, Europa y Asia
• Aumentará la disponibilidad a través de canales en la nube, incluido AWS Marketplace

Acerca de Antithesis
Antithesis es una forma completamente nueva de validar el correcto funcionamiento del software antes de su lanzamiento. Realiza una simulación paralela masiva y totalmente determinista que prueba años de producción real en pocas horas. Antithesis explora inteligentemente los detalles de su código base, inyectando estratégicamente fallos comunes para garantizar que el sistema siempre se comporte como se espera. La plataforma reproduce a la perfección cualquier error que encuentre en su entorno único para una depuración rápida. La empresa, con sede en el norte de Virginia, se fundó en 2018 y se lanzó de forma discreta en 2024. Para más información, visite https://antithesis.com/.

Acerca de Jane Street
Jane Street es una firma global de inversión y comercio con enfoque tecnológico. Fundada en el año 2000, la firma aporta un enfoque basado en la investigación y experiencia cuantitativa a los mercados de todo el mundo, con más de 3.000 empleados en oficinas en Nueva York, Londres, Hong Kong, Singapur y Ámsterdam. Para más información, visite www.janestreet.com.

Logo – https://mma.prnewswire.com/media/2836754/Antithesis_Logo.jpg